Effect of magnesium sulfate on induced opiate- withdrawal syndrome
Phase 3
Recruiting
- Conditions
- withdrawal of opiate.Mental and behavioural disorders due to use of opioids withdrawal stateF11.3
- Registration Number
- IRCT20190207042648N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
patients with Induced opiate withdrawal syndrome
Exclusion Criteria
Naloxane induced withdrawal
Ischemic heart disease
renal failure
Hepatic failure
Uncontrolled hypertension.
AIDS
Cerebrovascular disease
long-term treatment with calcium Chanel blocker
Diabetic neuropathy.
Allergy to magnesium compounds
Concomitant use of other substances such as methamphetamine, alcohol or other stimulants
Asthma.
In case of incomplete registration ,Lack of patient collaboration and patient inaccessibility (in providing required information)
Pregnancy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Opiate withdrawal score. Timepoint: at start and 0.5 and 2 hours after treatment. Method of measurement: By Opiate withdrawal scale.;MG serum level. Timepoint: start and after 2 hours. Method of measurement: MG serum level.
- Secondary Outcome Measures
Name Time Method